We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Cole F Heyer has been assisting clients through the Perm Visa process since 2023.

As of 2023, Cole F Heyer has succesfully submitted and recieved certification for 65 cases.

Cole F Heyer is located in Atlanta, GEORGIA, and has represented 37 employers for the Perm Visa Process

110
Cases Handled
65
Cases Certified
59.09%
Approval

Cases Handled by Cole F Heyer

Case Number Case Status Job Title Industry Name Employer Name Year
A-21112-77005 Certified-Expired Sales Engineers Pharmaceutical Preparation Manufacturing Alcon Vision Llc 2022
A-20230-88873 Certified Public Relations Specialists Research And Development In The Physical Engineering And Life Sciences Novartis Pharmaceuticals Corporation 2021
A-19354-98462 Certified Multimedia Artists And Animators Testing Laboratories And Services Xo Group Inc 2020
A-22180-80537 Certified Quality Control Analysts Research And Development In The Physical Engineering And Life Sciences Novartis Pharmaceuticals Corporation 2023
A-20317-20056 Certified Economists Research And Development In The Physical Engineering And Life Sciences Novartis Pharmaceuticals Corporation 2021
A-19137-06661 Certified-Expired Epidemiologists Research And Development In The Physical Engineering And Life Sciences Novartis Pharmaceuticals Corporation 2020
A-20261-00710 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Novartis Pharmaceuticals Corporation 2021
A-21207-22194 Certified Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Novartis Pharmaceuticals Corporation 2022
A-22216-99931 Denied Food Scientists And Technologists Soft Drink Manufacturing The Cocacola Company 2023
A-20252-96850 Certified Engineers All Other Research And Development In The Physical Engineering And Life Sciences Novartis Pharmaceuticals Corporation 2021